Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06823037 · ClinicalTrials.gov registry record · NA
Hormonal Contraception Access Through Pharmacist Prescribing Implementation
A NA study of Contraception and Pharmaceutical Services, sponsored by EMPOWERX.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT06823037 is a NA study of Contraception and Pharmaceutical Services that is actively recruiting participants, run by EMPOWERX. The registered enrollment target is 150 participants, below the 453-participant average among 72 other Contraception trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06823037, a NA study of Contraception and Pharmaceutical Services, is actively recruiting participants, sponsored by EMPOWERX.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if use of the HAPPI software can improve pharmacist-provided birth control services. The main questions it aims to answer are: 1. Does the HAPPI software make it easier for pharmacists to provide birth control services in their pharmacy? 2. Does the HAPPI software make it easier for patients to access birth control? Researchers will compare pharmacists' implementation and patients' access when using the HAPPI software and when not using the HAPPI software to see if the software improves implementation and access. Participants will include pharmacists and patients. Pharmacists will be asked to provide birth control services as normal while using the HAPPI software. Patients will be asked to receive birth control services from a pharmacist as normal, while using the HAPPI software.
Conditions Studied
Interventions
- OTHER HAPPI software
Study Locations (1)
California
- EmpoweRx, Inc - Del Mar
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-10-09 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06823037
The ClinicalTrials.gov registry entry for NCT06823037 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 453-participant average among 72 other Contraception trials with a reported enrollment target (67% lower). The listed sponsor is EMPOWERX, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Contraception appearing as the primary indexed condition, and to 1 intervention - of which HAPPI software is the first listed.
NCT06823037 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06823037 about?
NCT06823037 is a clinical study titled "Hormonal Contraception Access Through Pharmacist Prescribing Implementation". The goal of this clinical trial is to learn if use of the HAPPI software can improve pharmacist-provided birth control services. The main questions it aims to answer are: 1. Does the HAPPI software make it easier for pharmacists to provide birth control services in their pharmacy? 2. Does the HAPPI...
What is the current status of trial NCT06823037?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2025-10-09. Estimated completion is 2026-08-31.
What conditions does trial NCT06823037 study?
This clinical trial studies the following conditions: Contraception, Pharmaceutical Services, Access and Linkage to Healthcare, Technology Use.
What interventions are being tested in trial NCT06823037?
The interventions under investigation include: HAPPI software (OTHER).
Who is sponsoring clinical trial NCT06823037?
This trial is sponsored by EMPOWERX, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06823037 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contraception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Patient-clinical Linkages to Improve Trust and Engagement in Postpartum Healthcare
RECRUITING · NA
-
Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements
RECRUITING · NA
-
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
RECRUITING · NA
-
Contraceptive Efficacy Study of Ovaprene
RECRUITING · NA
-
Intervening on Women's Health for Rural Young Cancer Survivors
RECRUITING · NA
-
Patient-centered Information on Permanent Contraception
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.